New trends in antiviral chemotherapy.
D000547:Amantadine / Q000627:therapeutic use; D000818:Animals; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use; D006801:Humans; D007369:Interferon Inducers; D007372:Interferons / Q000627:therapeutic use; D014176:Protein Biosynthesis / Q000187:drug effects; D011684:Purine Nucleosides / Q000627:therapeutic use; D011741:Pyrimidine Nucleosides / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors; D012254:Ribavirin / Q000627:therapeutic use; D013329:Structure-Activity Relationship
D000998:Antiviral Agents; D007369:Interferon Inducers; D011684:Purine Nucleosides; D011741:Pyrimidine Nucleosides; D018894:Reverse Transcriptase Inhibitors; D012254:Ribavirin; D007372:Interferons; D000547:Amantadine